We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
A U.S. district court has dismissed patent infringement claims against Hikma Pharmaceuticals, ruling that Takeda Pharmaceuticals USA lacked any “plausible claim to relief” in the case. Read More
The FDA is calling out two dietary supplement makers for a host of issues, including drug-like promotional claims and GMP issues that render their products adulterated. Read More
An Indian court is ordering Pfizer to honor an earlier promise to dump large quantities of its steroid Medrol prior to the drug’s expiration date. Read More
The FDA is proposing a surveillance plan for Merck’s Gardasil 9 to screen for four potential adverse risks associated with human papillomavirus vaccines. Read More